Plasma treated with amotosalen and ultraviolet A light retains activity for hemostasis after 5 days post-thaw storage at 1 to 6o C.

about

Plasma treated with amotosalen and ultraviolet A light retains activity for hemostasis after 5 days post-thaw storage at 1 to 6o C.

Item

http://www.wikidata.org/entity/Q40354711

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Plasma treated with amotosalen ...... ost-thaw storage at 1 to 6o C.

@en

type

Item

label

Plasma treated with amotosalen ...... ost-thaw storage at 1 to 6o C.

@en

prefLabel

Plasma treated with amotosalen ...... ost-thaw storage at 1 to 6o C.

@en

P1476

Plasma treated with amotosalen ...... post-thaw storage at 1 to 6o C

@en

P2093

Anna Erickson

http://www.w3.org/2001/XMLSchema#string

Katie Waldhaus

http://www.w3.org/2001/XMLSchema#string

Laurence Corash

http://www.w3.org/2001/XMLSchema#string

Nina Mufti

http://www.w3.org/2001/XMLSchema#string

Norman Huang

http://www.w3.org/2001/XMLSchema#string

Richard J Benjamin

http://www.w3.org/2001/XMLSchema#string

Tovo David

http://www.w3.org/2001/XMLSchema#string

P2860

Fresh frozen plasma prepared with amotosalen HCl (S-59) photochemical pathogen inactivation: transfusion of patients with congenital coagulation factor deficiencies.

Photochemically treated fresh frozen plasma for transfusion of patients with acquired coagulopathy of liver disease.

A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura.

Study of three patients with thrombotic thrombocytopenic purpura exchanged with solvent/detergent-treated plasma: is its decreased protein S activity clinically related to their development of deep venous thromboses?

Plasma components: properties, differences, and uses.

Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial.

Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: current state of art and future perspectives.

Effect of plasma and red blood cell transfusions on survival in patients with combat related traumatic injuries.

Trends in United States blood collection and transfusion: results from the 2013 AABB Blood Collection, Utilization, and Patient Blood Management Survey.

INTERCEPT plasma: comparability with conventional fresh-frozen plasma based on coagulation function--an in vitro analysis.

P304

997-1006

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TRF.13973

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Salvador Rico

P577

2017-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28150310

http://www.w3.org/2001/XMLSchema#string